tiprankstipranks
Trending News
More News >
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market

Puma Biotechnology (PBYI) Financial Statements

Compare
663 Followers

Puma Biotechnology Financial Overview

Puma Biotechnology's market cap is currently $307.89M. The company's EPS TTM is $0.17; its P/E ratio is 8.48; Puma Biotechnology is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 230.47M$ 235.64M$ 228.03M$ 253.16M$ 225.11M
Gross Profit$ 166.06M$ 172.96M$ 172.94M$ 189.45M$ 185.74M
Operating Income$ 30.97M$ 32.64M$ 23.72M$ 1.29M$ -30.40M
EBITDA$ 48.08M$ 47.52M$ 21.89M$ -4.69M$ -35.71M
Net Income$ 30.28M$ 21.59M$ 2.00K$ -29.13M$ -59.99M
Balance Sheet
Cash & Short-Term Investments$ 100.97M$ 95.94M$ 81.07M$ 82.11M$ 93.39M
Total Assets$ 213.33M$ 230.53M$ 222.06M$ 226.59M$ 244.22M
Total Debt$ 74.08M$ 111.49M$ 114.28M$ 116.64M$ 120.95M
Net Debt$ 4.86M$ 26.91M$ 38.08M$ 53.51M$ 35.66M
Total Liabilities$ 121.21M$ 177.09M$ 200.45M$ 229.03M$ 250.17M
Stockholders' Equity$ 92.13M$ 53.44M$ 21.61M$ -2.45M$ -5.95M
Cash Flow
Free Cash Flow$ 38.86M$ 14.37M$ -22.83M$ 20.65M$ -19.25M
Operating Cash Flow$ 38.92M$ 27.01M$ -15.83M$ 20.65M$ 800.00K
Investing Cash Flow$ -20.44M$ -19.13M$ 7.10M$ -10.88M$ 23.30M
Financing Cash Flow$ -33.85M$ 0.00$ 12.22M$ -31.93M$ 100.00K
Currency in USD

Puma Biotechnology Earnings and Revenue History

Puma Biotechnology Debt to Assets

Puma Biotechnology Cash Flow

Puma Biotechnology Forecast EPS vs Actual EPS